346 related articles for article (PubMed ID: 17251024)
21. Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
Waschbisch A; Wintterle S; Lochmüller H; Walter MC; Wischhusen J; Kieseier BC; Wiendl H
Arthritis Rheum; 2008 Nov; 58(11):3600-8. PubMed ID: 18975328
[TBL] [Abstract][Full Text] [Related]
22. [Histological data in inflammatory myositis].
Mikol J; Polivka M
Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
[TBL] [Abstract][Full Text] [Related]
23. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M
Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218
[TBL] [Abstract][Full Text] [Related]
24. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies.
Civatte M; Bartoli C; Schleinitz N; Chetaille B; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):70-9. PubMed ID: 15634233
[TBL] [Abstract][Full Text] [Related]
25. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
[No Abstract] [Full Text] [Related]
26. Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies.
De Paepe B; Racz GZ; Schröder JM; De Bleecker JL
Acta Neuropathol; 2004 Jul; 108(1):37-42. PubMed ID: 15138776
[TBL] [Abstract][Full Text] [Related]
27. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
De Paepe B; Creus KK; De Bleecker JL
Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Fas/Fas ligand in inclusion body myositis.
Fyhr IM; Oldfors A
Ann Neurol; 1998 Jan; 43(1):127-30. PubMed ID: 9450780
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.
De Bleecker JL; Meire VI; Declercq W; Van Aken EH
Neuromuscul Disord; 1999 Jun; 9(4):239-46. PubMed ID: 10399751
[TBL] [Abstract][Full Text] [Related]
30. [Expression of adhesion molecules in idiopathic inflammatory myopathies. Immunohistochemical study of 17 cases].
Liprandi A; Figarella-Branger D; Daniel L; Lepidi H; Bartoli C; Pellissier JF
Ann Pathol; 1999 Mar; 19(1):12-8. PubMed ID: 10320905
[TBL] [Abstract][Full Text] [Related]
31. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
33. The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases.
Adams EM; Kirkley J; Eidelman G; Dohlman J; Plotz PH
Proc Assoc Am Physicians; 1997 May; 109(3):275-85. PubMed ID: 9154644
[TBL] [Abstract][Full Text] [Related]
34. Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies.
Reimann J; Schnell S; Schwartz S; Kappes-Horn K; Dodel R; Bacher M
J Neuropathol Exp Neurol; 2010 Jun; 69(6):654-62. PubMed ID: 20467327
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
Bertorini TE
Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
[TBL] [Abstract][Full Text] [Related]
37. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
38. Monocyte/macrophage differentiation in dermatomyositis and polymyositis.
Rostasy KM; Piepkorn M; Goebel HH; Menck S; Hanefeld F; Schulz-Schaeffer WJ
Muscle Nerve; 2004 Aug; 30(2):225-30. PubMed ID: 15266639
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform.
Sousa AR; Lane SJ; Cidlowski JA; Staynov DZ; Lee TH
J Allergy Clin Immunol; 2000 May; 105(5):943-50. PubMed ID: 10808175
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
